Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App




Next-Generation Hemoglobin Analyzer Uniquely Ensures Bi-Directional Data Management Future Proofing

By LabMedica International staff writers
Posted on 04 May 2015
A new point-of-care (POC) diagnostics analyzer delivers quantitative laboratory-accurate hemoglobin and hematocrit results in one simple test and uniquely enables upgrade with data management functionality as required, giving broad flexibility over future connectivity options via its bi-directional interface.

The new robust, portable Hemo Control from EKF Diagnostics (Cardiff, UK) provides accuracy and reliability of results (imprecision of <2%) from 25 seconds for blood banks, hospitals, and clinics. More...
It can easily communicate with in-house systems: using the new LIS2-A2 communication standard, this bi-directional interface allows the analyzer to connect directly to third party software and enable simple integration with LIS (Laboratory Information System) middleware. (LIS2-A2 succeeds the ASTM communication standard commonly used for small to mid-size analyzers and is easier to integrate than POCT-1A.)

This cost-effective basic device stores up to 4,000 patient results and offers enhanced on-board Data Management (DM) functions following upgrade with the DM “add pack” if required at a later date. In addition to enabling lists to be sent directly from the LIS to Hemo Control, DM upgrade also offers barcode identification of patients, operators, cuvette LOT and control materials, as well as quality control with lock-out functions and ability to add comments to results. Hemo Control requires no docking station when handling on-board data management as it uses simple cable connections (e.g. RS-232 to USB or LAN), or integrated Bluetooth technology available with Hemo Control Manager—the top-of-the-range device available with preinstalled DM functions.

“Our new Hemo Control with flexible DM upgrade and bi-directional connectivity is ideal for customers who wish to keep their connectivity options open. This may be because they are planning on future connection of POC devices to the LIS but have yet to decide, or they may need to split costs for budgetary reasons by upgrading at a later date,” said Katja Lemburg, global product manager for hematology.

This compact analyzer is user friendly with step-by-step on-screen instructions, needs no calibration or maintenance, and requires minimal user training. Furthermore, Hemo Control uses NXT shape microcuvette technology, which enables improved finger stick sample collection by virtually eliminating appearance of air bubbles.

Related Links:

EKF Diagnostics
Hemo Control with “Add Pack” options




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gel Cards
DG Gel Cards
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.